-
Study aim
-
Anti-inflamatory effect of anaheal 500in mandibular third molar surgery
Determination of the effect of Anaheal on pain, trismus, ecchymosis after surgery
Comparison of each of the above variables in the groups of Anaheal and Ibrophon 400 after surgery
Incidence of dry socket in all groups
-
Design
-
non-Randomised, superiority, parallel group trial with double blinded outcome assessment.
-
Settings and conduct
-
The place of the study is dental clinic of babol university of medical sciences, where the patients and the main investigators are blinded by the envelopes of medicines by the pharmacist.
-
Participants/Inclusion and exclusion criteria
-
The population under study are those who refer to the clinic of the Faculty of Dentistry of Babol University of Medical Sciences in order to surgical removal of mandibular third molar. The number of samples based on similar studies, are 50 patients aged between 15 to 25 years old and candidates for mandibular third molar surgery. Patients are divided into two groups of recipients of Anaheall (Bromelin) and an ibuprofen 400 receptor.
Non-admission criteria for our study include an adverse drug reaction to an anaheal or ibuprofen 400, smoking, taking some medications such as corticosteroids and bisphosphonates, diseases like diabetes, anemia, or other immunosuppressive diseases. hemorrhagic diseases, or the use of anticoagulant drugs, contraindication for adrenalin use, pregnancy, radiotherapy in the head and neck, and also the presence of pericoronitis or any pathological lesions associated with third molar teeth. The impacted wisdom teeth are classified according to Pell & Gregory Classes I, II-A, B and Class III and C are excluded.
-
Intervention groups
-
Patients are divided into two groups of recipients of Anaheal(Bromelin) and ibuprofen400 receptor, size of each groups are 25.
-
Main outcome variables
-
Replacing Ibuprofen400 with Anaheal After Surgery